Dernières nouvelles

Information non disponible

Ball G, Lemieux C, Cameron D, Seftel MD

Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in Canada

Article de revue

Curr Oncol, 29 (3), 2022.

Résumé | Liens:

Signaler des ajouts ou des modifications